ResMed (ASX:RMD) Chief Executive Michael Farrell sold 3,000 of his shares in the company on the New York Stock Exchange, with an aggregate market value of about $845,700, according to a Friday filing with the Australian bourse.
Following the transaction, Farrell owns nearly 146.6 million shares and other units outstanding in the company, per the filing.